Hypotensive efficacy and cerebroprotective action of beta blocker metoprolol

QR-Code

Hypotensive efficacy and cerebroprotective action of beta blocker metoprolol

The aim of the study was to investigate hypotensive and cerebroprotective activity ofmetoprolol inpatients with essential arterial hypertension (EAR). In all participants, 24-hour blood pressure (BP) monitoring, cerebral perfusion scintigraphy, and cognitive function assessment were performed at bas...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	N. L. Afanasyeva, V. F. Mordovin, N. Yu. Efimova, G. V. Semke, I. Yu. Efimova
Format:	Artikel
Sprache:	Russisch
Veröffentlicht:	«FIRMA «SILICEA» LLC 2005-02-01
Schriftenreihe:	Российский кардиологический журнал
Schlagworte:	arterial hypertension metoprolol cognitive function
Online-Zugang:	https://russjcardiol.elpub.ru/jour/article/view/2495
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge

COMPARATIVE STUDY OF NEW DRUG OF LONG ACTING METOPROLOL TARTRATE - EGILOK RETARD AND ORIGINAL DRUG OF METOPROLOL SUCCINATE – BETALOC ZOK IN PATIENTS WITH MILD TO MODERATE ARTERIAL HYPERTENSION
von: J. V. Lukina, et al.
Veröffentlicht: (2015-12-01)

EFFICACY AND SAFETY OF CONTROLLED RELEASE METOPROLOL TARTRATE IN PATIENTS WITH ARTERIAL HYPERTENSION: ERA STUDY RESULTS
von: O. L. Barbarash, et al.
Veröffentlicht: (2016-01-01)

EFFECTS OF CARVEDILOL AND METOPROLOL ON VEGETATIVE REGULATION OF HEART AND MICROCIRCULATION IN PATIENTS WITH HYPERTENSION AND HIGH BODY MASS
von: A. R. Kiselev, et al.
Veröffentlicht: (2016-01-01)

WHAT DOES PROVIDE A CLINICAL EFFICACY OF METOPROLOL?
von: E. V. Kuleshova
Veröffentlicht: (2016-01-01)

COMPARISON BETAXOLOL AND METOPROLOL TARTRATE THERAPIES IN PATIENTS WITH ARTERIAL HYPERTENSION ASSOCIATED WITH STABLE ANGINA
von: A. A. Anderzhanova, et al.
Veröffentlicht: (2016-01-01)

COMPARISON OF THERAPIES BASED ON CARVEDILOL AND METOPROLOL IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT OR OBESITY. THE FIRST RESULTS OF CAMELLIA TRIAL
von: S. Y. Martsevich, et al.
Veröffentlicht: (2016-01-01)

ANTIHYPERTENSIVE AND ANTIOXIDATIVE EFFECTS OF CARVEDILOL AND METOPROLOL IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT/OBESITY
von: V. A. Nevzorova, et al.
Veröffentlicht: (2016-01-01)

EFFECTS OF AMLODIPIN AND METOPROLOL ON AUTONOMIC SYSTEM IN EMOTIONAL AND COLD TESTS IN HYPERTENSIVE PATIENTS WITH DIFFERENT PSYCHOLOGICAL PROFILE
von: M. P. Rubanova, et al.
Veröffentlicht: (2016-01-01)

EFFECT OF METOPROLOL THERAPY ON THE ARTERIAL STIFFNESS
von: V. E. Oleynikov, et al.
Veröffentlicht: (2016-01-01)

TREATMENT OF PATIENTS WITH ESSENTIAL HYPERTENSION 1-2 GRADE WITH METOPROLOL TARTRATE AND ANALYSIS OF HEART RATE VARIABILITY
von: V. E. Oleinikov, et al.
Veröffentlicht: (2015-12-01)

Metoprolol retard effectiveness in patients with arterial hypertension and disturbed circadian blood pressure rhythm
von: P. P. Tikhonov, et al.
Veröffentlicht: (2006-08-01)

Investigate if Metoprolol and Troxerutin Could Prevent Cardiotoxicity Mitigated by Doxorubicin
von: Fouad Zeidan Hamzah, et al.
Veröffentlicht: (2025-07-01)

EFFICACY AND SAFETY OF METOPROLOL SUCCINATE IN HIGH DOSES IN PATIENTS WITH STABLE COURSE OF ISCHEMIC HEART DISEASE
von: S. N. Tolpygina, et al.
Veröffentlicht: (2016-01-01)

Comparative Characteristics of Beta-Blockers in Patients with Congenital Long QT Syndrome
von: A. Yu. Proshlyakov, et al.
Veröffentlicht: (2021-07-01)

TREATMENT OF CHRONIC HEART FAILURE: FOCUS ON METOPROLOL SUCCINATE
von: O. D. Ostroumova, et al.
Veröffentlicht: (2015-12-01)

METOPROLOL AND CARVEDILOL IN THERAPY OF ACUTE MYOCARDIAL INFARCTION: WHEN AND WHICH DRUG TO PREFER
von: B. N. Garifullin, et al.
Veröffentlicht: (2016-01-01)

Isotherms and Thermodynamic Parameters of Metoprolol Drug Adsorption on the Prepared Mesoporous Silica
von: Manar A. Sachit, et al.
Veröffentlicht: (2024-03-01)

COMPARISON OF THE METABOLIC EFFECTS OF CARVEDILOL AND METОPROLOL IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT AND OBESITY. THE CAMELLIA TRIAL
von: S. Y. Martsevich, et al.
Veröffentlicht: (2016-01-01)

EFFECT OF METOPROLOL ON COGNITIVE FUNCTION IN HYPERTENSIVE PATIENTS OF YOUNG TO MIDDLE AGE
von: S. A. Smakotina, et al.
Veröffentlicht: (2016-01-01)

Fixed-dose combination of ivabradine and metoprolol in a patient with stable coronary artery disease: a case report
von: A. M. Shimkevich
Veröffentlicht: (2021-10-01)

Carbohydrate metabolism parameters in angina patients treated with metoprolol and its combination with trimetazidine
von: E. V. Bochkareva, et al.
Veröffentlicht: (2012-08-01)

CHANGING SYTOLIC AND DIASTOLIC LV FUNCTION IN CHRONIC HEART FAILURE UNDER THE INFLUENCE OF METOPROLOL
von: T. S. Jahangirov, et al.
Veröffentlicht: (2001-10-01)

THE ROLE OF S-AMLODIPINE IN ARTERIAL HYPERTENSION THERAPY WITH COMBINATION OF CALCIUM CHANNEL BLOCKERS AND BETA-BLOCKERS
von: M. A. Maksimova, et al.
Veröffentlicht: (2015-09-01)

The role of beta-blockers in the treatment of hypertension in 2018 ESC/ESH guidelines
von: A. O. Konradi, et al.
Veröffentlicht: (2018-12-01)

COMPARATIVE CLINICAL AND PHARMACOLOGICAL CHARACTERISTICS OF HYPOTENSIVE EFFICACY AND SAFETY OF SHORT AND PROLONGED ACTION SLOW CALCIUM CHANNELS BLOCKERS: NIFEDIPINE, CORDAFLEX-RETARD AND NIFECARD XL IN PATIENTS WITH MILD TO MODERATE ARTERIAL HYPERTENSION
von: V. G. Kukes, et al.
Veröffentlicht: (2003-08-01)

Clinical efficacy of nebivolol and metoprolol in complex treatment of patients with coronary heart disease and II-III functional class chronic heart failure
von: A. G. Evdokimova, et al.
Veröffentlicht: (2005-04-01)

BETA-ADRENOBLOCKERS IN XXI CENTURY: EPOCH END OR IMMORTALITY BEGINNING? A VIEW OF ORDINARY CARDIOLOGIST
von: L. N. Malaj
Veröffentlicht: (2016-01-01)

Indap hypotensive efficacy, influence on cardiac structural and functional changes, and autoregulation of peripheral artery tonus
von: N. V. Belokopytova, et al.
Veröffentlicht: (2004-04-01)

Indap hypotensive efficacy, influence on cardiac structural and functional changes, and autoregulation of peripheral artery tonus
von: N. V. Belokopytova, et al.
Veröffentlicht: (2004-04-01)

CLINICAL EFFICACY AND PECULIARITY OF COMPLIANCE WITH 48-WEEK LONG THERAPY WITH EGILOK RETARD IN PATIENTS WITH MILD TO MODERATE HYPERTENSION
von: V. E. Oleynikov, et al.
Veröffentlicht: (2016-01-01)

CLINICAL AND ECONOMICAL ASSESSMENTS OF METOPROLOL TARTRATE/SUCCINATE USAGE IN PATIENTS WITH ISCHEMIC HEART DISEASE
von: M. V. Soura
Veröffentlicht: (2016-01-01)

Disturbances of peripheral vascular reaction to vasoactive substances and hypotensive therapy efficacy
von: G. I. Livshitz, et al.
Veröffentlicht: (2005-04-01)

Tianeptine in the treatment of patients with arterial hypertension and depression
von: G. V. Semke, et al.
Veröffentlicht: (2008-02-01)

EFFICACY AND SAFETY OF VASOACTIVE BETA-BLOCKERS IN ACUTE PHARMACOLOGICAL TEST IN HYPERTENSIVE PATIENTS OF DIFFERENT AGES
von: O. V. Fedorishina, et al.
Veröffentlicht: (2016-01-01)

Efficient photocatalytic degradation of metoprolol using activated carbon supported NiFe-layered double hydroxides (NiFe-LDH/C) under solar-driven simulation
von: Raphael N. Biata, et al.
Veröffentlicht: (2025-09-01)

Antiischemic effects of metoprolol and the risk of carbohydrate metabolism disturbances in angina patients
von: E. V. Bochkareva, et al.
Veröffentlicht: (2012-12-01)

PHARMACOECONOMIC ANALYSIS OF CARVEDILOL THERAPY IN PATIENTS WITH ARTERIAL HYPERTENSION AND METABOLIC RISK FACTORS (ACCORDING TO THE CAMELLIA STUDY)
von: S. Y. Martsevich, et al.
Veröffentlicht: (2016-01-01)

THE ROLE OF BETA-BLOCKERS IN THE TREATMENT OF CARDIOVASCULAR DISEASES IN PREGNANT WOMEN
von: R. I. Striuk, et al.
Veröffentlicht: (2015-12-01)

EFFECTS OF AMLODIPINE, FOSINOPRIL AND METOPROLOL ON HEMODYNAMICS IN HYPERTENSIVE PATIENTS
von: A. L. Hohlov, et al.
Veröffentlicht: (2015-12-01)

BETA-BLOCKERS IN THE TREATMENT OF ARTERIAL HYPERTENSION: EVIDENCE BASED DATA AND REAL PRACTICE
von: M. V. Leonova
Veröffentlicht: (2015-12-01)